Mark:

BIONUMERIK

Status Date:

06-03-2016

Registration Number:

3703574

Goods and Services:

Pharmaceutical products for the following diseases and medical conditions; cancer; sickle cell anemia; the toxicity of side-effects of chemotherapeutic treatment; neurotoxicity; adult respiratory distress syndrome; acute renal failure treatment; septic shock or shock/ischemia; ethanol-induced physiological symptoms ("Hang-over"); ethylene glycol poisoning; radiation exposure; osteoporosis; cardiomyopathy; diabetic neuropathy; diabetic opthalmopathy; diabetic angiopathy; diabetic nephropathy; hypertension; atherosclerosis and peripheral vascular disease; ischemia; gastrointestinal distress; patients exposed to toxic chemicals; heavy metal poisoning or exposure; complications arising from AIDS; alcoholism and complications arising therefrom; acetaminophen overdosage; the renal calculi (kidney stones); inhibiting angiogenesis; Wilson's disease; Treatment for reducing toxicity associated with diabetes treatments; inflammatory bowel disorder; complication arising from tobacco smoke exposure; venomous snakebite; patients undergoing kidney dialysis or peritoneal dialysis; chemotherapy/drug extravasation injury; lymphedema; chemotherapy- or drug-induced toxicity; platinum or alkylating agent overdose; hyperbaric toxicity; chemotherapy- or radiation-induced mucositis

Class:

Pharmaceutical and veterinary preparations

Published for Opposition Date:

07-25-2006

Mark Drawing Status:

Standart Character Mark

Business Name:

PANITCH SCHWARZE BELISARIO & NADEL LLP